FDAHealthJuly 9, 2025

Boothwyn Pharmacy LLC — Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy

⚠️ Subpotent Drug

Is this relevant to me?

Geography: Nationwide
Source agency: FDA
Category: Health
Published: July 9, 2025

U.S. Nationwide

What's affected?

Product: Semaglutide, 2.5 mg/mL injection, 4 mL, Boothwyn Pharmacy
Brand: Boothwyn Pharmacy LLC
Lot code: 03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025

Additional details

03202025@2, 03202025@3 and 03202025@4 BUD 07/18/2025

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 648 vials.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.